AP Biology Unit 4: Cell Communication and Cell Cycle — Free Review Games.

A ligand is the signaling molecule (such as a hormone) that binds to a specific receptor to initiate signal transduction.

The S (synthesis) phase is when the cell replicates its entire genome in preparation for cell division.

Mitosis produces two daughter cells that are genetically identical to the parent cell, each with the same chromosome number.

cAMP is a small intracellular molecule generated in response to receptor activation that relays and amplifies the signal inside the cell.

Negative feedback counteracts deviations from a set point, maintaining homeostasis by reducing the output when levels exceed the target.

Kinases transfer phosphate groups from ATP to target proteins, activating or deactivating them in signal transduction cascades.

The G2 checkpoint verifies that DNA replication during S phase is complete and checks for DNA damage before the cell enters mitosis.

Apoptosis is a genetically programmed process of cell self-destruction that eliminates damaged or unnecessary cells without triggering inflammation.

Steroids are lipid-derived, hydrophobic molecules that can diffuse directly through the phospholipid bilayer to bind intracellular receptors.

In positive feedback, the output enhances the original stimulus. Activated clotting factors recruit more platelets and clotting factors, amplifying the cascade.

A constitutively active Ras protein sends continuous growth signals downstream regardless of external stimuli, which can lead to uncontrolled cell proliferation and cancer.

Signal amplification occurs because each activated enzyme (e.g., kinase) can phosphorylate many substrate molecules, exponentially increasing the response at each cascade step.

p53 normally halts the cell cycle at the G1 checkpoint when DNA damage is detected. Without functional p53, damaged cells continue dividing, increasing cancer risk.

In quorum sensing, bacteria secrete autoinducer molecules; when concentration reaches a threshold (indicating high population density), gene expression changes coordinate group behaviors.

Phosphatases normally dephosphorylate and deactivate signaling proteins. Blocking this step keeps proteins phosphorylated and active, prolonging the signal.

Ligand-gated ion channels are transmembrane proteins that open or close in response to ligand binding, allowing ions to flow directly across the membrane. G protein-coupled receptors work through second messengers, not direct ion flow. Receptor tyrosine kinases activate intracellular kinase cascades. Intracellular receptors are located inside the cell, not on the surface.

During metaphase, the mitotic spindle aligns chromosomes along the metaphase plate (the equatorial plane of the cell). This alignment ensures each daughter cell receives one copy of each chromosome. Prophase involves chromosome condensation and spindle formation. Anaphase is when sister chromatids separate and move to opposite poles. Telophase is when nuclear envelopes re-form.

ATP is the primary energy currency in cells, and kinases transfer phosphate groups from ATP to target proteins during signal transduction. While GTP is used by G proteins and some other signaling molecules, the broader phosphorylation cascades rely on ATP. NADH is an electron carrier. cAMP is a second messenger derived from ATP but is not an energy source for phosphorylation.

Phosphatases remove phosphate groups from proteins, which typically inactivates those proteins and helps terminate signaling. They are essential for returning the cell to its resting state after a signal. Kinases (not phosphatases) add phosphate groups. Adenylyl cyclase produces cAMP. No enzyme 'transfers' a ligand to the nucleus in this manner.

Animal cells divide by cleavage furrow formation, where a contractile ring of actin and myosin II filaments constricts the cell membrane to pinch the cell into two daughter cells. Cell plate formation from Golgi vesicles is the plant cell mechanism. Nuclear envelope dissolution occurs in mitosis, not cytokinesis. Centriole separation occurs during mitosis to organize the spindle, not during cytokinesis.

Steroid hormones are lipid-soluble and can diffuse through the plasma membrane. Inside the cell, they bind intracellular receptors that, when activated, function as transcription factors to alter gene expression. This is different from peptide hormones, which bind surface receptors and use second messengers or phosphorylation cascades. Steroid hormones are not themselves converted into second messengers.

The correct order of mitosis is PMAT: Prophase (chromosomes condense, spindle forms), Metaphase (chromosomes align at equator), Anaphase (sister chromatids separate), and Telophase (nuclear envelopes re-form, chromosomes decondense). All other orderings represent incorrect sequences of these events.

G proteins are active when bound to GTP and inactive when GTP is hydrolyzed to GDP. If GTP hydrolysis is blocked, the G protein remains in its active (GTP-bound) form indefinitely, continuously stimulating downstream effectors such as adenylyl cyclase. This leads to uncontrolled, prolonged signaling — a mechanism exploited by cholera toxin, for example. The other choices describe unrelated or opposite effects.

The G1 checkpoint evaluates whether the cell is large enough, has sufficient nutrients and growth factors, and has intact (undamaged) DNA before committing to DNA replication. The spindle assembly checkpoint checks kinetochore attachment during mitosis. The G2 checkpoint verifies that DNA replication is complete and accurate. Chromatid separation occurs at anaphase, monitored by the spindle checkpoint.

One major advantage of multi-step cascades is signal amplification: each activated molecule can activate many downstream molecules, creating an exponential increase in signal strength. A single receptor-ligand interaction can ultimately trigger activation of thousands of effector molecules. Multiple steps do not inherently slow the response — many cascades are very fast. The other choices do not accurately describe the primary purpose of cascade complexity.

CDKs require binding to a cyclin protein to become active. Cyclin concentrations rise and fall at specific points in the cell cycle (hence the name 'cyclin'), so CDK activity tracks cyclin availability. When cyclins are degraded by the proteasome, CDKs become inactive again. This system precisely times cell cycle transitions. CDKs are not primarily regulated by phosphorylation from growth factor receptors alone, nor by nuclear sequestration or proteolytic cleavage.

Cyclin B partners with CDK1 to form MPF (maturation-promoting factor), which drives entry into and progression through mitosis. Degradation of cyclin B at the end of mitosis inactivates CDK1 and allows the cell to exit mitosis. If cyclin B cannot be degraded, CDK1 remains active and the cell is stuck in mitosis — it cannot re-enter G1 or proceed through cytokinesis normally. This is not a G1 arrest, S-phase skip, or apoptotic trigger.

Paracrine signaling involves locally released molecules that diffuse to and act on nearby target cells — they do not enter the bloodstream. Endocrine signaling involves hormones secreted into the bloodstream that travel to distant target cells throughout the body. Juxtacrine/contact-dependent signaling (not paracrine) requires cell-to-cell contact. Both paracrine and endocrine signals can bind either surface or intracellular receptors depending on the molecule.

In mitotic anaphase, cohesins linking sister chromatids are cleaved by separase, and kinetochore microtubules shorten to pull each sister chromatid to opposite poles. This ensures each daughter cell gets an identical copy of each chromosome. Homologous chromosome separation occurs in meiosis I, not mitosis. Spindle fiber dynamics involve both shortening and polar fiber elongation, but the mechanism is kinetochore-fiber shortening, not simply depolymerization 'pushing.' Random distribution would not give each cell a complete set.

Negative feedback occurs when the output of a system reduces the initial stimulus. When blood glucose rises after a meal, the pancreas secretes insulin. Insulin promotes glucose uptake by cells, lowering blood glucose back toward the set point, which in turn reduces the stimulus for further insulin secretion. This is classic negative feedback. Positive feedback would amplify the signal rather than dampen it. Insulin does not stimulate glucose production — that is glucagon's role.

Proto-oncogenes normally encode proteins that promote cell growth and division in a controlled manner. When a proto-oncogene is overexpressed (e.g., due to gene duplication) or gains a constitutively activating mutation, it becomes an oncogene driving uncontrolled cell proliferation. Excess growth factor receptors can signal without ligand, constitutively activating mitogenic pathways. Inactivating a checkpoint kinase and deleting a tumor suppressor both involve loss-of-function changes to negative regulators, not gain-of-function in a proto-oncogene. Mutating DNA repair genes increases mutation rate but is not itself an oncogene mechanism.

Receptor tyrosine kinases (RTKs) are activated when ligand binding causes two RTK monomers to come together (dimerize). The dimerized receptors then phosphorylate each other on tyrosine residues (transphosphorylation), creating docking sites for downstream signaling proteins such as Ras activators. RTKs do not work through adenylyl cyclase/cAMP (that is the G protein-coupled receptor pathway). RTKs are not G proteins and do not translocate to the nucleus to phosphorylate transcription factors directly.

Adenylyl cyclase converts ATP to cAMP, a key second messenger that activates protein kinase A (PKA). If adenylyl cyclase is constitutively active, cAMP accumulates continuously, keeping PKA persistently active. This leads to uncontrolled phosphorylation of PKA targets. Constitutively active adenylyl cyclase would increase, not decrease, cAMP. While phosphodiesterase does degrade cAMP, there is no built-in mechanism to automatically upregulate it enough to fully compensate. Adenylyl cyclase does not use or compete for GTP.

The spindle assembly checkpoint operates through the mitotic checkpoint complex (MCC), which includes Mad2. Unattached kinetochores catalyze conversion of Mad2 into its active form, which inhibits Cdc20, a co-activator of the APC/C ubiquitin ligase. APC/C-Cdc20 normally ubiquitinates securin (releasing separase to cleave cohesins) and cyclin B; its inhibition blocks anaphase onset. p53 and ATM are involved in DNA damage checkpoints, not the spindle assembly checkpoint. Cyclin B sequestration is not the mechanism used here.

The IP3/DAG pathway is activated when phospholipase C-beta (PLC-beta) cleaves PIP2 into IP3 and DAG. PLC-beta is activated by the Gq subunit of certain G proteins. If Gq has a gain-of-function mutation that prevents GTP hydrolysis, Gq remains permanently active, continuously stimulating PLC-beta and producing IP3/DAG without any ligand. A loss-of-function in PLC would decrease, not increase, IP3/DAG. RTK loss-of-function is unrelated to Gq signaling. PKA is downstream of the cAMP pathway, not the IP3/DAG pathway.

Tumor suppressors are recessive at the cellular level — both copies of the gene must be inactivated to remove the braking function on cell division (Knudson's two-hit hypothesis). In contrast, proto-oncogenes act in a dominant gain-of-function manner: a single activating mutation in one allele can produce an overactive protein that drives uncontrolled cell division, regardless of the normal allele. This asymmetry is fundamental to understanding carcinogenesis and hereditary cancer predispositions.

This classic experiment (originally performed by Masui and Markert with frog oocytes) demonstrated the existence of maturation-promoting factor (MPF), now known to be the CDK1/cyclin B complex. Active MPF from a mitotic cell can directly phosphorylate target proteins in a G2 cell — such as nuclear lamins, condensins, and the spindle apparatus — to drive mitotic entry. The effect is protein-based and immediate, not dependent on new mRNA translation. Chromosome transfer and securin degradation do not explain premature mitotic entry via cytoplasm injection.

After receptor-mediated endocytosis, the vesicle containing the receptor-ligand complex fuses with a lysosome, where low pH and hydrolytic enzymes degrade the complex. If receptors are degraded faster than new receptors are synthesized, the total number of surface receptors decreases, making the cell less responsive to subsequent stimulation — a process called receptor downregulation. This is a form of desensitization. Endocytosis occurs after the signal has already been initiated (not before), and the receptor does not migrate to the nucleus to inhibit transcription.

During meiosis I, bivalents (pairs of homologous chromosomes) are held together by chiasmata (physical crossover sites). The chiasmata are stabilized by cohesin on the chromosome arms. At anaphase I, separase cleaves arm cohesin, releasing the chiasmata and allowing homologs to separate. However, centromeric cohesin is protected from cleavage by shugoshin (Sgo1), keeping sister chromatids attached until meiosis II. In mitosis, all cohesin is cleaved simultaneously. This distinction is critical for the two-step separation characteristic of meiosis.

Normal cells exhibit contact inhibition: when they form a complete monolayer and touch neighboring cells, signaling pathways reduce CDK activity and arrest the cell cycle. Cells that have lost contact inhibition — a hallmark of cancer — ignore these stop signals and continue dividing even in a crowded environment, piling up into foci (multilayered clumps). This is distinct from apoptosis, which is programmed cell death, not continued growth. Loss of contact inhibition does not produce compensatory G1 arrest or increased growth factor secretion toward neighbors.

Cell-surface receptors (transmembrane receptors) are embedded in the plasma membrane and bind water-soluble (hydrophilic) ligands that cannot cross the lipid bilayer. Intracellular and nuclear receptors bind lipid-soluble molecules like steroid hormones that can diffuse through the membrane.

During metaphase, chromosomes are moved by spindle fibers to align at the metaphase plate (cell's equator). This alignment is essential before sister chromatids are separated. Prophase involves chromosome condensation, anaphase involves chromatid separation, and telophase involves nuclear envelope reformation.

G-proteins (GTP-binding proteins) act as relay molecules between a G-protein-coupled receptor and an effector enzyme such as adenylyl cyclase. When activated, they exchange GDP for GTP and either stimulate or inhibit adenylyl cyclase. Phosphodiesterase (not G-proteins) degrades cAMP.

G1 (Gap 1) is a growth phase where the cell increases in size and carries out normal metabolic activities. DNA replication occurs in S phase, chromatid separation occurs during anaphase of mitosis, and nuclear envelope breakdown happens during prophase.

In animal cells, cytokinesis occurs via a cleavage furrow, where a ring of actin microfilaments contracts to pinch the cell in two. Cell plate formation via Golgi-derived vesicles is the mechanism used by plant cells, which must build a new cell wall.

A ligand is any molecule that binds specifically to a receptor protein. Ligands can be hormones, neurotransmitters, or local regulators. Kinases add phosphate groups, and second messengers like cAMP are produced downstream of receptor activation.

Positive feedback amplifies or enhances the original stimulus, pushing the system further away from its initial state. This is useful for processes that need to be completed rapidly, such as childbirth contractions or blood clotting. Negative feedback returns a system to its set point.

Mitosis formally begins with prophase, during which chromatin condenses into visible chromosomes and the nuclear envelope breaks down. DNA replication completion marks the end of S phase (still interphase), and chromosome alignment occurs in metaphase, which is later in mitosis.

Endocrine signaling uses hormones transported through the bloodstream to distant targets, while paracrine signaling acts on nearby cells via local mediators. If the same molecule acts both locally and at a distance, it functions through both modes. Autocrine refers to a cell signaling itself.

CDKs are constitutively expressed but require binding to cyclin proteins to become active. Cyclins are synthesized and degraded at specific points in the cell cycle, so CDK activity fluctuates based on cyclin availability. Phosphatases regulate cyclin-CDK activity but do not degrade CDK proteins themselves.

The correct sequence is: ligand binds a G-protein-coupled receptor, the G-protein is activated and stimulates adenylyl cyclase, which converts ATP to cAMP (second messenger), and cAMP then binds the regulatory subunits of PKA, releasing and activating its catalytic subunits.

During anaphase, microtubules of the spindle shorten (depolymerize) to pull sister chromatids to opposite poles. If microtubule depolymerization is blocked, the cell would arrest at metaphase because chromosomes are aligned but cannot be separated. Taxol is a real drug that works by this mechanism.

Cascades of intermediary proteins allow signal amplification — one activated receptor can activate many G-proteins, each activating many enzyme molecules, exponentially increasing the response. Each step also provides a point at which the signal can be modulated, amplified, or terminated.

Oncogenes arise when proto-oncogenes are mutated to produce overactive or constitutively active proteins. A mutation preventing protein degradation would cause persistent stimulation of the cell cycle. Deletion or reduced expression would reduce growth-promoting signals, which does not cause cancer.

The spindle assembly checkpoint (SAC) prevents anaphase onset until all kinetochores are attached to spindle microtubules from opposite poles. Unattached kinetochores produce a 'wait' signal that inhibits the anaphase-promoting complex (APC/C), arresting the cell in metaphase.

RTKs are transmembrane receptors with intrinsic kinase activity. Upon ligand binding, they dimerize and cross-phosphorylate each other's tyrosine residues, then phosphorylate downstream relay proteins. GPCRs work through G-proteins and second messengers, not through direct kinase activity.

Tumor suppressor genes follow the 'two-hit hypothesis' — both alleles must be inactivated to lose tumor suppressor function. One functional allele is sufficient to prevent uncontrolled growth. Loss of both alleles eliminates the brake on cell cycle progression, enabling cancer development.

Ca²⁺ stored in the endoplasmic reticulum can be rapidly released into the cytoplasm upon signal initiation, providing a fast and highly amplifiable signal. The signal is reversed by Ca²⁺-ATPase pumps that sequester ions back. This speed and reversibility make Ca²⁺ an effective second messenger.

APC/C is a ubiquitin ligase that triggers anaphase by ubiquitinating securin (leading to its degradation) and cyclin B. Securin normally inhibits separase, the enzyme that cleaves cohesin holding sister chromatids together. Without APC/C activity, securin persists, separase stays inhibited, and sister chromatids cannot separate, arresting the cell in metaphase.

This pathway illustrates how a surface receptor signal is transduced through the cytoplasm (via cAMP and PKA) to alter gene expression. PKA phosphorylates CREB in the nucleus, which then drives transcription of CRE-containing genes. The original ligand does not enter the cell — the signal is relayed by second messengers.

p21 is a CDK inhibitor that blocks CDK4/6-cyclin D complexes, enforcing the G1 checkpoint. Cyclin D drives CDK4/6 to phosphorylate Rb, releasing E2F transcription factors to push cells into S phase. With p21 absent and cyclin D overactive, Rb is fully inactivated, and the cell loses the G1 restriction point, entering S phase without proper growth signals.

Scaffold proteins physically tether consecutive members of a signaling cascade, ensuring that activated enzymes are in immediate proximity to their substrates. This increases both speed and specificity of signaling and reduces inappropriate activation of similar molecules in adjacent pathways (cross-talk), a key advantage in cells with multiple simultaneous signals.

CDK1 (maturation-promoting factor, MPF) requires binding to cyclin B and activation by the phosphatase Cdc25, which removes inhibitory phosphate groups from CDK1. Inhibiting phosphatase activity prevents Cdc25 from activating CDK1-cyclin B, blocking entry into mitosis and arresting cells in G2.

Blocking one pathway in a cell with active compensatory pathways often leads to resistance. PI3K-Akt signaling promotes survival and can partially substitute for growth signals. Cancer cells frequently develop resistance to targeted therapies through pathway crosstalk and activation of bypass mechanisms, which is why combination therapies targeting multiple pathways are often more effective.

Proteins involved in homologous recombination (such as BRCA1/2 or RAD51) often serve dual roles: facilitating crossover in meiosis and repairing double-strand breaks detected at the G2/M checkpoint in mitosis. Loss of such a protein would impair both processes, leading to meiotic failure and mitotic genomic instability — a common feature of hereditary cancer syndromes.

Receptor proteins are specific to their ligands. Binding causes a conformational change that triggers downstream signaling. Receptors do not enter the nucleus (that is more characteristic of steroid hormone-receptor complexes), do not independently synthesize second messengers, and are not primarily responsible for ligand degradation.

During metaphase, the spindle apparatus is fully formed and chromosomes are aligned at the metaphase plate (cell equator). This alignment is essential before sister chromatids are separated in anaphase. Prophase involves chromatin condensation and spindle formation; anaphase involves separation; telophase involves nuclear envelope reformation.

Animal cells divide by a cleavage furrow formed by a contractile ring of actin and myosin filaments that tightens like a drawstring, pinching the cell into two. Cell plate formation from Golgi-derived vesicles is the plant cell mechanism. Nuclear envelope dissolution is part of mitosis, not cytokinesis.

Upon GPCR activation, the G protein exchanges its bound GDP for GTP and the alpha subunit dissociates from the beta-gamma complex to interact with effector proteins such as adenylyl cyclase. G proteins do not enter the nucleus, phosphorylate receptors, or transport ligands.

Endocrine signaling uses hormones released into the bloodstream to reach distant target cells throughout the body. Paracrine signaling acts on nearby cells over short distances. Autocrine signaling affects the same cell that secreted the molecule. Synaptic signaling occurs across narrow synaptic clefts between neurons.

Cyclins bind to CDKs, activating them to phosphorylate target proteins that drive the cell forward through cycle checkpoints. Cyclin levels rise and fall at specific phases, which ensures CDK activity is tightly regulated. Cyclins do not replicate DNA, degrade damaged DNA, or form spindle fibers.

S (synthesis) phase is when DNA replication occurs, producing two identical sister chromatids for each chromosome joined at the centromere. Cell growth primarily occurs in G1 and G2. Chromatid separation occurs in anaphase of mitosis. Nuclear envelope breakdown occurs during prophase.

RTKs have intrinsic kinase activity in their cytoplasmic domains. Upon ligand binding, they dimerize and cross-phosphorylate tyrosine residues, directly initiating downstream cascades. GPCRs use second messengers like cAMP. RTKs span the membrane. Lipid-soluble ligands bind intracellular receptors, not RTKs.

Adenylyl cyclase converts ATP to cAMP, a second messenger that activates protein kinase A (PKA). Permanently active adenylyl cyclase would flood the cell with cAMP, keeping PKA continuously active and amplifying downstream signals. This does not directly deplete calcium or inhibit phosphorylation broadly.

Cyclin B is required to activate CDK1 (also known as MPF), which drives the cell into mitosis. Without cyclin B, CDK1 remains inactive, and the cell cannot pass the G2/M checkpoint. Cyclins activate CDKs rather than suppress apoptosis, and the cell would not skip phases or accelerate mitosis.

Loss of contact inhibition in cancer typically involves dysregulation of cell cycle checkpoints. Overexpression of cyclins or loss of tumor suppressors like Rb means growth-inhibitory signals transmitted by cell-cell contact are ignored, and CDKs remain active. The other choices describe cellular defects not mechanistically linked to contact inhibition.

Positive feedback amplifies the original stimulus rather than dampening it. Oxytocin stimulates contractions that release more oxytocin in a self-reinforcing cycle that continues until the baby is born. Negative feedback would reduce contractions. The signal is endocrine (blood-borne), not strictly paracrine, and allosteric inhibition is an unrelated enzymatic concept.

Unattached kinetochores generate a 'wait' signal that inhibits the APC/C, an E3 ubiquitin ligase complex. APC/C normally ubiquitinates securin for degradation, releasing separase to cleave cohesin and allow chromatid separation. Blocking APC/C keeps securin intact, preventing premature anaphase. p53 is relevant to G1/DNA damage checkpoints, not SAC.

Colchicine prevents microtubule polymerization, so spindle fibers cannot form. Without spindle fibers, kinetochores remain unattached, triggering the spindle assembly checkpoint and arresting the cell in M phase. DNA replication does not require microtubules, and p53 responds to DNA damage, not microtubule disruption.

Cancer cells frequently exploit autocrine signaling by producing growth factors for their own receptors, allowing them to proliferate independently of external signals. The neuron-muscle example is synaptic signaling. Insulin release and its distant effects are endocrine signaling. Histamine acting on nearby cells is paracrine signaling.

Amplification arises from the enzymatic nature of kinases: one activated kinase molecule phosphorylates many substrates in a given time, each of which may activate yet more molecules. This branching, multiplicative effect means thousands of molecules are activated from a single receptor binding event. Phosphate groups serve regulatory, not energetic, roles in this context.

The G1/S checkpoint (restriction point) determines whether a cell should commit to dividing based on size, nutrients, growth factors, and DNA integrity. The G2/M checkpoint confirms that DNA has been fully and accurately replicated before allowing entry into mitosis. Spindle attachment is monitored at the SAC during M phase, not at G2/M.

PLC cleaves PIP2 into IP3 and DAG. IP3 travels to the endoplasmic reticulum, where it opens calcium channels to flood the cytoplasm with Ca2+, which activates calmodulin and other effectors. DAG remains membrane-associated and activates protein kinase C (PKC). cAMP is produced by a different pathway (adenylyl cyclase), and cyclin is unrelated to PLC products.

Normal Rb protein, when unphosphorylated, sequesters the transcription factor E2F, blocking S phase entry. CDKs phosphorylate Rb to release E2F and allow division. An oncogene (e.g., overactive Ras) drives excess CDK activity, while Rb loss means E2F is constitutively free regardless of CDK activity. Together they eliminate complementary controls, strongly promoting division. These mutations do not primarily suppress apoptosis or activate p53.

Neurofibromin accelerates Ras's intrinsic GTPase activity, converting active Ras-GTP to inactive Ras-GDP. Without functional NF1, Ras-GTP persists much longer, continuously activating downstream pathways like MAPK and PI3K that promote cell proliferation. This is analogous to oncogenic Ras mutations that reduce intrinsic GTPase activity, explaining the tumor-forming phenotype in NF1 patients.

p21 (CDKN1A) is a CKI that inhibits cyclin D-CDK4/6 and cyclin E-CDK2 complexes. When these CDKs are inhibited, they cannot phosphorylate Rb, so Rb remains bound to E2F, preventing transcription of S-phase genes and halting the cell before DNA replication. p21 does not ubiquitinate cyclins, repair DNA directly, or act at the spindle checkpoint.

Signaling crosstalk at transcription factors involves complex integration. If the two phosphorylation sites are independent and simultaneous, activity depends on the net outcome of competing modifications, which is determined by kinase and phosphatase rates, binding affinities, and structural consequences of each modification. Without knowing these parameters, no definitive prediction can be made. Real signaling integration is graded, not binary.

Released cytochrome c binds the adaptor protein Apaf-1, which oligomerizes to form the apoptosome. This platform recruits and activates procaspase-9 (initiator caspase), which then cleaves and activates executioner caspases (3, 6, 7) to carry out apoptosis. Cytochrome c does not directly degrade DNA, act as an electron donor for caspases, or bind Bcl-2 to inhibit it.

APC/C-Cdc20 ubiquitinates cyclin B (destroying CDK1 activity) and securin (releasing separase to cleave cohesins) to drive the metaphase-to-anaphase transition and mitotic exit. If Cdc20 cannot be fully activated, these substrates persist, CDK1 remains active, and separase is inhibited — cells become stuck in mitosis. APC/C does not control mitotic entry (that is driven by CDK1-cyclin B activation) or the G1/S transition directly.

Terminal differentiation is often enforced by stable epigenetic changes and expression of CKIs like p16/INK4a, which block CDK4/6 even when cyclin D is present. Without functional CDK4/6, Rb cannot be phosphorylated, E2F remains repressed, and S-phase genes are not transcribed. Neurons retain ribosomes, Rb, and S-phase genes; the block is at the level of CDK inhibition and chromatin accessibility, not transcriptional machinery absence.

Ligand-gated ion channels are transmembrane proteins that open or close in direct response to ligand binding, allowing ions to flow across the membrane. G protein-coupled receptors work through a separate G protein intermediary, not by directly forming a channel.

Cyclins bind to and activate cyclin-dependent kinases (CDKs), which then phosphorylate target proteins to drive the cell cycle forward. Cyclin concentrations rise and fall at specific points, creating waves of CDK activity. Cyclins do not themselves replicate DNA or degrade CDKs.

During anaphase, cohesion proteins holding sister chromatids together are cleaved, and the spindle fibers shorten, pulling each chromatid to opposite poles. In metaphase, chromosomes are aligned at the metaphase plate but have not yet separated.

Signal transduction follows three sequential stages: reception (a receptor binds the signaling molecule), transduction (the signal is relayed and often amplified through a series of molecular changes), and response (the cell carries out a specific activity). This order is fundamental to all signaling pathways.

A ligand is any molecule that binds specifically to a receptor. Epinephrine is the signaling molecule (first messenger) that binds the cell-surface receptor. The second messenger in this pathway is cAMP, which is produced after receptor activation.

The spindle apparatus, composed of microtubules, attaches to chromosomes at the kinetochore and is responsible for aligning chromosomes at the metaphase plate and subsequently pulling them apart during anaphase. DNA replication occurs in S phase, well before the spindle forms.

Positive feedback amplifies a response in the same direction as the initial stimulus. Oxytocin triggers contractions, which stimulate more oxytocin release, which triggers stronger contractions — this cycle continues until birth. Insulin release is negative feedback, reducing blood glucose back to a set point.

The G2 checkpoint acts as a quality control step, ensuring that DNA replication was completed accurately and that no DNA damage is present before the cell commits to mitosis. If damage is detected, the cell cycle is halted to allow for repair. Chromosome alignment occurs during metaphase, inside mitosis itself.

Adenylyl cyclase converts ATP into cAMP, the second messenger that activates protein kinase A (PKA). Without functional adenylyl cyclase, cAMP cannot be produced, and the signal cannot be relayed downstream — effectively blocking the pathway. The receptor-ligand interaction itself would be unaffected.

At the G1 checkpoint, cyclin D-CDK4 complexes phosphorylate the retinoblastoma protein (Rb). Phosphorylated Rb releases the transcription factor E2F, which then drives expression of genes needed for S phase entry, including cyclin E. Cyclin B-CDK1 (MPF) drives the G2-to-M transition, not G1.

Signal amplification occurs because each activated protein in a cascade can activate many downstream molecules. For example, one activated G protein can activate many adenylyl cyclase molecules, each producing many cAMP molecules, each activating many PKA enzymes — resulting in a massive response from a tiny signal.

Growth factors often activate the PI3K-Akt pathway, which promotes cell survival by phosphorylating and inactivating pro-apoptotic proteins such as Bad. If these survival signals are strong enough, they can override the p53-mediated apoptotic response triggered by DNA damage — a mechanism commonly exploited by cancer cells.

Cell-type-specific responses arise because cells express different combinations of receptors and intracellular signaling proteins. The same ligand binding to different receptor subtypes, or activating different downstream pathways, can produce entirely different outcomes — for example, acetylcholine slows heart rate but stimulates skeletal muscle contraction.

Protein phosphatases remove phosphate groups from phosphorylated proteins, inactivating them. This is critical for turning off signals after the response is complete and for resetting the system so it can respond again. Kinases add phosphate groups; phosphatases remove them — they act as opposing regulators.

During anaphase, spindle microtubules must shorten (depolymerize) to pull sister chromatids to opposite poles. If depolymerization is blocked, the forces needed to separate chromatids cannot be generated, halting the cell at this stage. Taxol, a chemotherapy drug, works precisely through this mechanism.

Paracrine signaling involves local chemical mediators that diffuse short distances to affect nearby cells, without entering general circulation. Endocrine signaling uses hormones secreted into the bloodstream that travel to distant target organs. Juxtacrine/contact-dependent signaling requires direct contact, not paracrine.

DNA replication during S phase doubles the total amount of DNA, so the cell goes from 2n to 4n DNA content. The chromosome number remains 2n (diploid) because the two sister chromatids remain joined at the centromere — they are counted as one chromosome until anaphase. The cell only becomes 2n again after mitosis and cytokinesis.

IP3 is a second messenger produced from PIP2 by phospholipase C activation. IP3 travels to the endoplasmic reticulum and opens calcium channels, releasing Ca2+ into the cytoplasm. Ca2+ then activates downstream targets. Without IP3, this calcium release cannot occur, blocking any pathway that depends on cytoplasmic Ca2+ as a signal.

p53 is the 'guardian of the genome.' When activated by DNA damage, it induces expression of CDK inhibitors (pausing the cell cycle), activates DNA repair genes, and — if damage is too severe — triggers apoptosis by activating pro-apoptotic genes such as Bax. Ras promotes cell division; Cyclin B drives mitosis entry; PKA mediates cAMP-dependent signals.

Upon ligand binding, RTKs dimerize and undergo autophosphorylation of tyrosine residues, creating docking sites for downstream signaling proteins like Ras activators. This is distinct from GPCRs, which activate heterotrimeric G proteins as the first transduction step and often (but not always) use second messengers. Both RTKs and GPCRs can ultimately regulate gene expression.

In the Wnt signaling pathway, APC is part of the destruction complex that phosphorylates beta-catenin, marking it for proteasomal degradation. Without functional APC, beta-catenin is not degraded and accumulates, translocating to the nucleus where it acts as a co-activator of proliferation genes. APC is a classic tumor suppressor; its mutation is a major driver of colorectal cancer.

The APC/C, when active, ubiquitinates securin and cyclin B, leading to their degradation. Securin normally inhibits separase; when securin is degraded, separase cleaves cohesin, releasing sister chromatids. The MCC inhibits APC/C until every kinetochore is attached to spindle fibers from opposite poles — preventing chromosome mis-segregation that could cause aneuploidy.

Signal transduction pathways routinely branch, allowing a single upstream signal to activate multiple downstream targets simultaneously. Rapid cytoplasmic responses (seconds) reflect post-translational modifications of pre-existing proteins, while gene expression responses take longer (minutes to hours). Both can originate from the same receptor activation event through different branches of the pathway.

Proto-oncogenes encode proteins that normally promote cell growth in a regulated way. Mutations that cause constitutive (ligand-independent) activation convert proto-oncogenes to oncogenes — gain-of-function mutations that drive uncontrolled proliferation. HER2 overexpression in breast cancer is a real-world example. This is distinct from tumor suppressor loss-of-function, which removes a brake rather than pushing the accelerator.

Cyclin degradation is essential for turning off CDK activity at specific cell cycle transitions. For example, cyclin B degradation (via APC/C-mediated ubiquitination) is required to inactivate CDK1 and allow mitotic exit. If cyclins cannot be degraded, CDK activity remains high and cells become trapped in mitosis, unable to complete division and re-enter interphase.

Transmembrane receptors span the plasma membrane and bind water-soluble (hydrophilic) ligands that cannot cross the lipid bilayer. Intracellular and nuclear receptors are found inside the cell and bind lipid-soluble molecules like steroid hormones.

Cyclin concentrations rise and fall in a predictable pattern throughout the cell cycle. They are synthesized and then rapidly degraded at specific checkpoints, which drives progression through the cycle when paired with cyclin-dependent kinases (CDKs).

The centromere is the constricted region of a chromosome where sister chromatids are joined together. The kinetochore is a protein complex that assembles on the centromere and attaches to spindle fibers, but the physical joining of chromatids occurs at the centromere itself.

During metaphase, chromosomes are aligned at the metaphase plate (the cell's equator) by spindle fibers attached to kinetochores. This alignment ensures that when sister chromatids separate in anaphase, each daughter cell receives one copy of each chromosome.

When a ligand activates a GPCR, the receptor changes shape and acts as a guanine nucleotide exchange factor: the G protein's alpha subunit releases GDP and binds GTP, activating it. The G protein itself is not a kinase and does not phosphorylate targets directly.

The G1 checkpoint (also called the restriction point in mammals) evaluates cell size, nutrient availability, growth factor signals, and DNA integrity before committing the cell to S phase. The G2 checkpoint checks for DNA replication accuracy, and the spindle assembly checkpoint confirms proper chromosome attachment.

Autocrine signaling occurs when a cell releases a signaling molecule and also has receptors for that same molecule, allowing it to respond to its own signal. This is distinct from paracrine signaling (affecting nearby cells) and endocrine signaling (affecting distant cells via the bloodstream).

Phosphodiesterase degrades cAMP into AMP, which terminates the signal. When inhibited, cAMP levels remain elevated and continue to activate PKA. This demonstrates how signal termination is just as important as signal initiation for proper cellular responses.

Entry into mitosis is triggered by the activation of the cyclin B-CDK1 complex (also called MPF, maturation-promoting factor). This complex phosphorylates nuclear lamins, causing nuclear envelope breakdown, and initiates chromosome condensation. CDK1 activity is held in check until cyclin B accumulates sufficiently.

When ligand binding causes two RTKs to dimerize, each receptor's kinase domain phosphorylates tyrosine residues on its partner (transphosphorylation). These phosphorylated tyrosines serve as docking sites for intracellular signaling proteins, launching the downstream cascade.

Mitosis produces two genetically identical daughter cells, each with the same chromosome number as the parent cell. Although DNA is replicated before division (producing sister chromatids), the separation of chromatids in anaphase ensures each daughter cell receives 46 chromosomes. This contrasts with meiosis, which halves the chromosome number.

Securin inhibits separase. When the anaphase-promoting complex (APC/C) ubiquitinates securin for proteasomal destruction, separase is freed to cleave the cohesin complexes holding sister chromatids together. This triggers anaphase and the separation of chromatids to opposite poles.

Multi-step cascades allow signal amplification (one molecule activates many at each step), signal integration (multiple pathways converge), and multiple regulatory checkpoints. Direct receptor-to-DNA signaling would lack these control mechanisms and would limit the cell's ability to modulate responses.

Animal cells lack a rigid cell wall, so they divide by pinching inward using a contractile ring of actin and myosin II filaments, forming a cleavage furrow. Plant cells, constrained by their wall, instead build a new cell wall (cell plate) inward from Golgi-derived vesicles.

After a meal, rising blood glucose stimulates pancreatic beta cells to release insulin. Insulin promotes glucose uptake by cells and glycogen synthesis in liver and muscle, reducing blood glucose back to the set point. This is classic negative feedback: the response opposes the stimulus.

Gap junctions are channels made of connexin proteins that directly connect the cytoplasms of adjacent cells, allowing ions, second messengers, and small molecules (under about 1 kDa) to pass freely. This enables rapid electrical and chemical coupling without molecules entering the extracellular space.

In the Wnt pathway, beta-catenin normally undergoes proteasomal degradation in the absence of Wnt signal. When it accumulates, it enters the nucleus and activates transcription of growth-promoting genes such as cyclin D and c-myc. Permanent activation mimics a continuously 'on' Wnt signal, promoting uncontrolled proliferation — a hallmark of several cancers.

Unattached kinetochores generate a 'wait' signal by catalyzing MCC formation, which blocks APC/C. Once every kinetochore is properly attached to microtubules from opposing poles (amphitelic attachment), MCC production stops, existing MCC is disassembled, and APC/C becomes active, targeting cyclin B and securin for degradation to drive anaphase.

Contact inhibition is partly mediated by E-cadherin, which at high cell density signals through beta-catenin and other pathways to suppress proliferative signaling. Loss of E-cadherin function (common in epithelial cancers) removes this brake, allowing cells to continue dividing beyond normal density limits.

Signal specificity and versatility arise from the unique 'molecular circuitry' each cell type expresses — different receptor isoforms, scaffolding proteins, downstream effectors, and transcription factors. This means the same ligand can produce different outcomes in a liver cell versus a muscle cell, and different ligands converging on shared pathways can produce identical outcomes.

CKIs such as p21 and p27 bind to cyclin-CDK complexes and inhibit their activity, enforcing cell cycle arrest at checkpoints. If CKIs are constantly degraded, CDK activity is unrestrained, checkpoints are bypassed, and the cell cycles rapidly and without appropriate quality control — a pro-oncogenic state.

DNA polymerase cannot replicate the very ends of linear chromosomes, so telomeres shorten with each division. After sufficient shortening, cells enter replicative senescence or apoptosis. Telomerase uses an RNA template to add TTAGGG repeats back to telomere ends, enabling indefinite division in stem cells and most cancer cells — a key hallmark of cancer.

PP2A is a broad-spectrum serine/threonine phosphatase that dephosphorylates many signaling proteins, terminating their activity. Inhibiting PP2A allows phosphorylated signaling proteins to accumulate, prolonging and amplifying multiple pathways simultaneously. This is one reason PP2A is considered a tumor suppressor — its loss promotes oncogenic signaling.

Chromosome movement in anaphase depends on the controlled depolymerization of kinetochore microtubules (flux and poleward movement). Taxol stabilizes microtubules, preventing depolymerization, which activates the spindle assembly checkpoint and prevents anaphase onset. Cells arrest in mitosis and cannot segregate chromosomes. This is the basis for taxol's anti-cancer activity.

The action potential is a textbook positive feedback loop: depolarization opens voltage-gated Na+ channels, causing more depolarization, which opens more channels. This would be fatal if it continued, but the system is self-terminating: Na+ channels inactivate and K+ channels open, driving repolarization. Effective positive feedback in biology is always bounded by a termination event.

Cell-surface receptors (also called transmembrane receptors) are embedded in the plasma membrane and bind water-soluble signaling molecules that cannot cross the lipid bilayer. Intracellular and nuclear receptors are located inside the cell and bind lipid-soluble signals like steroid hormones.

During metaphase, chromosomes are aligned at the metaphase plate (the cell's equatorial plane) by spindle fibers. This alignment ensures that each daughter cell receives one copy of each chromosome when they are pulled apart in anaphase.

Cyclins are regulatory proteins whose concentrations rise and fall at specific points in the cell cycle. When cyclin binds to a cyclin-dependent kinase (CDK), the complex becomes active and phosphorylates target proteins that drive the cell into the next phase. Cyclins are then degraded, resetting the cycle.

In animal cells, cytokinesis occurs via a cleavage furrow — a ring of actin filaments contracts, pinching the cell in two. Plant cells use a different mechanism: vesicles fuse to form a cell plate. The other choices describe telophase events or plant-specific processes.

When a ligand binds to a GPCR, the receptor undergoes a conformational change that allows it to act as a guanine nucleotide exchange factor, causing the G protein to exchange GDP for GTP, activating it. The G protein then dissociates and activates downstream effectors such as adenylyl cyclase.

Sister chromatids remain joined at the centromere through prophase and metaphase. At the start of anaphase, the protein cohesin is cleaved, allowing sister chromatids to separate and be pulled to opposite poles by spindle fibers.

Protein kinases catalyze the transfer of a phosphate group from ATP to specific amino acids (typically serine, threonine, or tyrosine) on target proteins. This phosphorylation changes the target protein's shape and activity. Removing phosphate groups is the role of protein phosphatases.

G1 (first gap phase) is primarily a growth phase in which the cell increases in size and synthesizes the proteins and organelles needed to replicate its DNA. DNA replication occurs in S phase, chromosome condensation in prophase of mitosis, and sister chromatid separation in anaphase.

Contact inhibition is the normal mechanism by which cells stop dividing when they contact adjacent cells. Loss of contact inhibition is a hallmark of cancer cells. The spindle assembly and G2/M checkpoints monitor chromosome attachment and DNA integrity, not cell density.

Adenylyl cyclase catalyzes the conversion of ATP to cAMP, the second messenger that activates protein kinase A (PKA), which in turn activates glycogen phosphorylase. Inhibiting adenylyl cyclase prevents cAMP synthesis, blocking the entire downstream cascade and halting glycogen breakdown.

Multi-step cascades allow signal amplification: a single activated receptor can activate many G proteins, each of which activates many enzyme molecules, etc. Each step also represents a regulatory point where the signal can be modulated, integrated with other signals, or terminated.

MPF is a cyclin-CDK complex (specifically cyclin B bound to CDK1) that accumulates during G2 and triggers entry into mitosis at the G2/M checkpoint. It phosphorylates proteins needed for chromosome condensation, spindle formation, and nuclear envelope breakdown.

Apoptosis is programmed cell death characterized by activation of caspases (protease enzymes), DNA fragmentation, cell shrinkage, and formation of apoptotic bodies that are engulfed by phagocytes. Cell swelling and bursting describes necrosis. Senescence is cell cycle arrest, not death.

Phosphodiesterase (PDE) hydrolyzes cAMP to 5'-AMP, rapidly decreasing second messenger concentration and terminating the signal. This is essential for signal specificity and duration control. Protein phosphatases (not PDE) dephosphorylate kinases, and GTPase activity (intrinsic to G proteins) hydrolyzes GTP.

The G2/M checkpoint monitors for complete and accurate DNA replication. If DNA is incompletely replicated, regulatory proteins inhibit the cyclin B-CDK1 (MPF) complex, preventing mitosis from initiating. Apoptosis may occur if damage is irreparable, but the first response is cell cycle arrest.

Upon ligand binding, RTKs typically dimerize and cross-phosphorylate tyrosine residues on each other (autophosphorylation), creating docking sites for downstream signaling proteins. GPCRs work through associated G proteins and do not have intrinsic kinase activity. Both receptor types are transmembrane proteins.

MPF exhibits positive feedback: once active, MPF activates Cdc25 phosphatase, which removes inhibitory phosphates from CDK1, generating more active MPF. This creates a switch-like, irreversible commitment to mitosis. The other choices describe negative feedback or inhibitory mechanisms.

Cell signaling and the cell cycle are distinct processes. Cells in G0 still express surface receptors and maintain functional signal transduction machinery. They can respond to signals by changing gene expression, metabolism, or secretion without necessarily re-entering the cell cycle.

A constitutively active RTK sends continuous growth signals even without ligand, mimicking a permanently bound state. This drives uncontrolled cell proliferation — a hallmark of cancer. Oncogenes result from gain-of-function mutations, so they increase rather than decrease signaling.

Checkpoint kinases Chk1 and Chk2 are activated by DNA damage sensors and transmit the arrest signal (partly via p53 and CDK inhibitors). Inhibiting these kinases prevents the arrest signal from being relayed, allowing cells with damaged DNA to enter mitosis. This can lead to chromosomal errors, mutations, or aneuploidy in daughter cells.

Signal specificity depends not only on the receptor but on the downstream signaling proteins and transcription factors present in the cell. The same signal transduced through different molecular contexts can produce entirely different cellular responses — a concept called signal integration. This explains tissue-specific hormone responses.

If the tumor suppressor normally inhibits a CKI (i.e., it inhibits the inhibitor), losing the tumor suppressor removes this inhibition — so CKI becomes more active, blocking cyclin-CDK complexes and arresting the cycle. This is a double-negative: loss of suppressor increases inhibitor activity, paradoxically slowing proliferation. Wait — re-reading: the tumor suppressor inhibits a CKI. So loss of the suppressor means the CKI is no longer inhibited → CKI is more active → CDK activity is reduced → cell cycle slows. That means answer A is correct. The question tests careful multi-step logic.

APC is a core component of the destruction complex that targets beta-catenin for degradation. Without functional APC, the complex cannot phosphorylate beta-catenin, so it accumulates and translocates to the nucleus, constitutively activating growth genes. APC mutations are among the most common in colorectal cancer — a classic example of a tumor suppressor loss-of-function.

APC/C normally ubiquitinates securin (releasing separase) and cyclin B (inactivating CDK1) only after all kinetochores are properly attached. Premature APC/C activation would cleave securin and activate separase before proper attachment, causing sister chromatids to separate from misaligned chromosomes — resulting in aneuploidy in daughter cells.

Scaffold proteins physically tether multiple signaling components (e.g., kinases in a MAPK cascade) together. This increases local concentrations, speeds up sequential reactions, and prevents cross-talk with other pathways — enhancing both the speed and specificity of signal transmission without themselves being enzymatically active.

G protein-coupled receptors (GPCRs) are transmembrane receptors that, upon ligand binding, activate associated G proteins by causing GDP to be replaced with GTP. Receptor tyrosine kinases work through a different mechanism involving dimerization and autophosphorylation, not G proteins.

Mitosis proceeds in the order: Prophase (chromosomes condense), Metaphase (chromosomes align at the plate), Anaphase (sister chromatids separate), Telophase (nuclear envelopes reform). The mnemonic PMAT helps recall this sequence.

CDK inhibitor proteins (CKIs) bind to and inactivate cyclin-CDK complexes, preventing the cell from progressing through the cell cycle. Cyclins actually activate CDKs. MPF (maturation-promoting factor) is a cyclin-CDK complex that promotes cell cycle progression.

Reception is the first stage of signal transduction, in which a signaling molecule (ligand) binds to a receptor protein, inducing a conformational change. Transduction is the subsequent conversion of that signal into a form that can elicit a cellular response.

During anaphase, cohesin proteins holding sister chromatids together are cleaved, centromeres split, and the spindle fibers shorten, pulling sister chromatids to opposite poles. In metaphase, chromosomes are aligned but not yet separated.

Paracrine signals act locally, diffusing short distances to affect nearby cells. Endocrine signals (hormones) travel through the bloodstream to distant targets. Direct cell-to-cell contact describes juxtacrine signaling.

Phosphodiesterase hydrolyzes cAMP into AMP, effectively terminating the signal by reducing cAMP concentration. Adenylyl cyclase, not phosphodiesterase, converts ATP to cAMP. Protein kinase A is activated by cAMP binding, not by phosphodiesterase.

S-phase cyclins must be degraded after DNA replication to allow proper progression through the cycle. If S-phase cyclins persist, CDK activity remains high, potentially causing cells to re-initiate replication origins and over-replicate DNA — a hallmark of genomic instability.

When DNA damage or incomplete replication is detected, checkpoint kinases (Chk1/Chk2) phosphorylate and inactivate Cdc25 phosphatase, preventing it from removing inhibitory phosphates on CDK1. This keeps the CDK1-Cyclin B complex inactive, blocking mitotic entry.

Nitric oxide is a small, nonpolar gas that readily diffuses across the hydrophobic lipid bilayer without needing a membrane receptor. Inside smooth muscle cells, NO activates guanylyl cyclase, producing cGMP and causing muscle relaxation and vasodilation.

Upon ligand binding, RTK monomers come together (dimerize), and each subunit phosphorylates tyrosine residues on the other (transphosphorylation). This activates the receptor and creates docking sites for downstream signaling proteins. G protein activation is specific to GPCRs, not RTKs.

Oncogenes are mutated versions of proto-oncogenes that produce hyperactive or constitutively active signaling proteins (such as mutant Ras locked in GTP-bound form). This mimics persistent growth factor signaling, driving continuous proliferation even without extracellular signals. Tumor suppressors, when lost, also contribute to cancer but through a different mechanism.

IP3 is produced when phospholipase C cleaves PIP2. IP3 then diffuses to the ER and opens calcium channels, releasing Ca2+ into the cytoplasm. DAG also results from PIP2 cleavage but activates protein kinase C rather than triggering calcium release. cAMP acts through a separate pathway involving adenylyl cyclase.

Animal cells undergo cytokinesis via a cleavage furrow, where a ring of actin and myosin filaments contracts to pinch the cell in two. Plant cells cannot do this because of their rigid cell wall; instead, they build a cell plate from Golgi-derived vesicles that fuses to form a new wall between daughter cells.

When a proto-oncogene acquires a gain-of-function mutation that causes its protein product to be permanently active, it becomes an oncogene. This drives uncontrolled cell proliferation. In contrast, tumor suppressor mutations are typically loss-of-function and require both alleles to be inactivated (two-hit hypothesis).

The spindle assembly checkpoint monitors kinetochore-microtubule attachment. Unattached kinetochores generate a wait signal by producing MCC, which inhibits APC/C. Once all kinetochores achieve proper bipolar attachment, MCC production stops, APC/C is activated, securin is degraded, and separase cleaves cohesin to allow anaphase.

In signal transduction, receptor desensitization (down-regulation) is analogous to feedback inhibition — prolonged exposure to a ligand leads to receptor phosphorylation, internalization (endocytosis), or degradation, reducing cellular sensitivity. This prevents over-stimulation, much like end-product inhibition prevents metabolite accumulation.

Enzyme cascades achieve signal amplification because each activated enzyme can catalyze many reactions before being inactivated. In the MAPK cascade, one activated upstream kinase phosphorylates and activates many copies of the next kinase, and so on. This multiplicative amplification allows a single extracellular molecule to elicit a dramatic intracellular response.

In the intrinsic pathway, pro-apoptotic Bcl-2 family members (e.g., Bax, Bak) permeabilize the outer mitochondrial membrane, releasing cytochrome c. Cytochrome c then assembles with Apaf-1 and procaspase-9 to form the apoptosome, activating caspase-9 which activates executioner caspases. Bcl-2 itself is anti-apoptotic and inhibits cytochrome c release.

Signal integration refers to a cell's ability to process and combine multiple signals to produce a context-dependent response. When a single protein can trigger opposing pathways, the amplitude, duration, and subcellular localization of the signal determine which pathway dominates. This is critical in decisions like cell survival versus apoptosis in development and cancer.

Rb normally sequesters E2F transcription factors in its hypophosphorylated state. Cyclin D-CDK4/6 complexes phosphorylate Rb, releasing E2F. When Rb is completely lost, E2F is constitutively free, permanently activating S-phase genes regardless of mitogenic signals. This is a classic two-hit tumor suppressor mechanism.

DNA damage activates sensor kinases ATM and ATR, which phosphorylate and activate Chk1 and Chk2. These checkpoint kinases phosphorylate Cdc25 phosphatase, targeting it for degradation or cytoplasmic sequestration. Without active Cdc25, CDK1 cannot be dephosphorylated and activated, so cells remain arrested in G2. p53/p21 also contribute but act more slowly via transcriptional regulation.

Gap junctions and plasmodesmata form cytoplasmic bridges between adjacent cells, allowing small molecules (ions, second messengers like cAMP, metabolites) to pass directly from cell to cell. This enables coordinate regulation of neighboring cells. Endocrine signals travel through blood; juxtacrine involves membrane proteins on adjacent cell surfaces but not cytoplasmic continuity.

The spindle assembly checkpoint ensures each chromosome is correctly attached to microtubules from both poles (bipolar attachment) before anaphase begins. A defective SAC allows premature anaphase, so chromosomes can be mis-segregated (aneuploidy). G1/S checkpoint defects cause mutations and double-strand breaks but not the whole-chromosome gains and losses characteristic of SAC failure.

Phosphatases are essential counterparts to kinases — they dephosphorylate proteins, reversing their activation state. This ensures signals are transient and cells can return to baseline or respond to new signals. Without phosphatases, once a signaling protein were phosphorylated it could not be inactivated. cAMP is degraded by phosphodiesterase, not phosphatases.

During metaphase, spindle fibers attach to kinetochores on each chromosome and tension arranges all chromosomes along the cell's midline, called the metaphase plate. This alignment ensures each daughter cell will receive one copy of every chromosome. Prophase is incorrect because during prophase chromosomes condense and the spindle begins to form, but chromosomes have not yet aligned.

When a ligand-bound GPCR acts as a guanine nucleotide exchange factor, it causes the alpha subunit to release GDP and bind GTP. This GTP-bound form is the active state. The alpha subunit then dissociates from the beta-gamma dimer and activates downstream effectors. Hydrolysis of GTP back to GDP (choice A) is actually what INACTIVATES the G protein, making it a common but important distractor.

Cyclins are regulatory proteins whose concentrations fluctuate throughout the cell cycle. They must bind to their partner CDKs before the CDKs can become active. Active cyclin-CDK complexes then phosphorylate target proteins that advance the cell through the cycle. Cyclins do not replicate DNA themselves (choice A); that is the function of DNA polymerase and associated replication machinery.

When two RTKs dimerize after ligand binding, each receptor phosphorylates specific tyrosine residues on its partner in a process called transautophosphorylation. These phosphotyrosine residues then serve as docking sites for downstream signaling proteins, initiating the signal transduction cascade. Choice A is incorrect because ligand affinity is a property of the receptor-ligand interaction, not of receptor-receptor dimerization.

Exit from mitosis requires the destruction of cyclin B by the anaphase-promoting complex/cyclosome (APC/C). This degradation inactivates CDK1, which is required to reverse the phosphorylation events that drive mitotic entry. Without cyclin B degradation, CDK1 remains active and cells cannot exit mitosis — they remain arrested after anaphase begins. Choice A is incorrect because CDK1 is already bound to the accumulated cyclin B and would be constitutively active, not absent.

Positive feedback occurs when a response enhances or amplifies the original stimulus rather than diminishing it. Here, contractions trigger more oxytocin, which causes stronger contractions in a self-reinforcing loop. Choices A and C are incorrect because the eventual cessation of contractions after birth is not evidence of negative feedback — it simply means the stimulus (the baby) has been removed, ending the loop. Positive feedback loops are inherently self-terminating once the triggering condition is resolved.

Plant cells form a cell plate during cytokinesis. Golgi-derived vesicles carrying cell wall materials migrate to the equatorial plane along phragmoplast microtubules and fuse, building the cell plate outward until it merges with the existing plasma membrane. Animal cells instead use a contractile ring of actin and myosin (choice A), which is impossible in plant cells because the rigid cell wall prevents inward pinching.

PKA is normally held inactive by regulatory subunits bound to its catalytic subunits. When cAMP binds the regulatory subunits, they release the catalytic subunits, which are then free to phosphorylate target proteins. If adenylyl cyclase is always active, cAMP levels remain chronically elevated, keeping regulatory subunits permanently dissociated and PKA constitutively active. Choice C is a partial truth — phosphodiesterase does degrade cAMP — but a constitutively active enzyme continuously replenishes cAMP faster than phosphodiesterase can clear it, so the net effect is sustained elevation.

Contact inhibition involves cell-surface proteins (including cadherins and certain receptor tyrosine kinases) that transmit stop-growth signals when cells are densely packed. These pathways converge on tumor suppressor proteins that block CDK activity or activate p53. Loss-of-function mutations in these suppressors remove the density-sensing brake, allowing uncontrolled proliferation. Choice C is incorrect because p53 is a tumor suppressor — when functional, it promotes cell cycle arrest or apoptosis in response to stress; constitutive p53 activation would suppress, not drive, division.

The G1/S transition is controlled by the Rb (retinoblastoma) pathway. In quiescent cells, Rb is hypophosphorylated and binds E2F transcription factors, repressing genes needed for S-phase entry. Growth-factor-induced cyclin D accumulation activates CDK4 and CDK6, which hyperphosphorylate Rb. Hyperphosphorylated Rb releases E2F, which then drives transcription of cyclin E, cyclin A, and DNA replication genes. This is a multi-step pathway connecting extracellular signal to cell cycle commitment. Choice B is incorrect because cyclin D does not degrade p53; MDM2 is the primary p53 negative regulator, and its activation is a separate pathway.